Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
| Autor: | Latifi, Yllka *, Moccetti, Federico *, Wu, Melinda, Xie, Aris, Packwood, William, Qi, Yue, Ozawa, Koya, Shentu, Weihui, Brown, Eran, Shirai, Toshiaki, McCarty, Owen J., Ruggeri, Zaverio, Moslehi, Javid, Chen, Junmei, Druker, Brian J., López, Jose A., Lindner, Jonathan R. * |
|---|---|
| Zdroj: | In Blood 4 April 2019 133(14):1597-1606 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|